Allergan

(AGN) - Get Report

reported higher third-quarter sales and earnings that beat analysts' expectations by a penny.

The Irvine, Calif., health care company earned $54.6 million, or 41 cents a share, up from $47 million, or 34 cents a share, excluding certain one-time costs and credits, in the year-ago third quarter. According to a

First Call/Thomson Financial

survey, 12 analysts expected the company to earn 40 cents a share.

Sales rose to $381.6 million from $346.8 million last year.

The company also said it expects fourth-quarter revenue of $400 million to $415 million. Fourth-quarter EPS will be about 20% higher than the year-ago period, when the company earned 40 cents a share. Analysts are looking for the company to earn 47 cents a share in the fourth quarter.